Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Orford

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Critical Care (London, England)|January 10, 2013
Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequencesDeborah Cook, Ellen McDonald, Orla Smith, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) Trial: Study Protocol and Statistical Analysis PlanAidan Burrell, Sze Ng, Kelly Ottosen, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 1, 2024
Corrigendum to "Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) trial: Study protocol and statistical analysis plan" [Crit Care Resuscit 25 (2023) 118-125]Aidan Burrell, Sze Ng, Kelly Ottosen, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 1, 2024
<i>Corrigendum to</i>: A survey of Australian public opinion on using comorbidity to triage intensive care patients in a pandemicWinston Cheung, Vasi Naganathan, John Myburgh, et al.
Intensive Care Medicine|October 16, 2024
Correction: Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenationAidan Burrell, Michael J Bailey, Rinaldo Bellomo, et al.
Intensive Care Medicine|August 20, 2024
Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenationAidan Burrell, Michael J Bailey, Rinaldo Bellomo, et al.
JAMA|January 18, 2020
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical TrialTomoko Fujii, Nora Luethi, Paul J Young, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
The Lancet. Respiratory Medicine|September 29, 2022
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Critical Care (London, England)|January 10, 2013
Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequencesDeborah Cook, Ellen McDonald, Orla Smith, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) Trial: Study Protocol and Statistical Analysis PlanAidan Burrell, Sze Ng, Kelly Ottosen, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|May 1, 2024
Corrigendum to "Blend to Limit OxygEN in ECMO: A RanDomised ControllEd Registry (BLENDER) trial: Study protocol and statistical analysis plan" [Crit Care Resuscit 25 (2023) 118-125]Aidan Burrell, Sze Ng, Kelly Ottosen, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 1, 2024
<i>Corrigendum to</i>: A survey of Australian public opinion on using comorbidity to triage intensive care patients in a pandemicWinston Cheung, Vasi Naganathan, John Myburgh, et al.
Intensive Care Medicine|October 16, 2024
Correction: Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenationAidan Burrell, Michael J Bailey, Rinaldo Bellomo, et al.
Intensive Care Medicine|August 20, 2024
Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenationAidan Burrell, Michael J Bailey, Rinaldo Bellomo, et al.
JAMA|January 18, 2020
Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical TrialTomoko Fujii, Nora Luethi, Paul J Young, et al.
JAMA|November 2, 2014
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patientsRobert A Fowler, Nicole Mittmann, William Geerts, et al.
Trials|December 22, 2014
Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trialRobert A Fowler, Nicole Mittmann, William H Geerts, et al.
The Lancet. Respiratory Medicine|September 29, 2022
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort studyCarol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Pageof 5